Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.24
Delayed Data
As of 4:00pm ET
 +0.18 / +4.43%
Today’s Change
3.61
Today|||52-Week Range
11.15
-30.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues14.0M7.9M44.4M8.7M
 
 
 
 
 
Cost of Goods Sold499.0K624.0K855.0K--
 
 
 
 
Depreciation And Amortization1.3M939.0K545.0K565.0K
 
 
 
 
 
 
Operating ExpensesGross Income12.2M6.3M43.0M--
 
 
 
 
General Expenses47.7M47.0M42.7M45.4M
 
 
 
 
 
Research And Development33.0M34.1M27.7M28.2M
 
 
 
 
 
Total Operating Expenses49.5M48.6M44.1M46.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.5M-40.7M296.0K-37.3M
 
 
 
 
 
Extraordinary Credit0.00--7.3M0.00
 
 
Extraordinary Charge0.00-2.3M-4.2M-2.0M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.4M-42.9M3.4M-39.3M
 
 
 
 
 
Income Taxes0.00-362.0K-989.0K-133.0K
 
 
 
 
Minority Interest0.000.000.00-7.0K
 
 
Net Income-35.4M-42.6M4.4M-39.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.8M55.8M68.2M69.7M
 
 
 
 
 
Shares To Calculate EPS Diluted34.8M55.8M68.2M69.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.02-$0.76$0.06-$0.56
 
 
 
 
 
EPS Diluted-$1.02-$0.76$0.06-$0.56